Search Page

1

Cite

Share

Diagnostic Approach to Atypical Parkinsonian Syndromes.

McFarland NR. McFarland NR. Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1117-42. doi: 10.1212/CON.0000000000000348. Continuum (Minneap Minn). 2016. PMID: 27495201 Free PMC article. Review.

Cite

Share

2

Cite

Share

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.

Bluett B, Pantelyat AY, Litvan I, Ali F, Apetauerova D, Bega D, Bloom L, Bower J, Boxer AL, Dale ML, Dhall R, Duquette A, Fernandez HH, Fleisher JE, Grossman M, Howell M, Kerwin DR, Leegwater-Kim J, Lepage C, Ljubenkov PA, Mancini M, McFarland NR, Moretti P, Myrick E, Patel P, Plummer LS, Rodriguez-Porcel F, Rojas J, Sidiropoulos C, Sklerov M, Sokol LL, Tuite PJ, VandeVrede L, Wilhelm J, Wills AA, Xie T, Golbe LI. Bluett B, et al. Among authors: mcfarland nr. Front Neurol. 2021 Jul 1;12:694872. doi: 10.3389/fneur.2021.694872. eCollection 2021. Front Neurol. 2021. PMID: 34276544 Free PMC article. Review.

Cite

Share

3

Cite

Share

Current Management and Emerging Therapies in Multiple System Atrophy.

Burns MR, McFarland NR. Burns MR, et al. Among authors: mcfarland nr. Neurotherapeutics. 2020 Oct;17(4):1582-1602. doi: 10.1007/s13311-020-00890-x. Neurotherapeutics. 2020. PMID: 32767032 Free PMC article. Review.

Cite

Share

4

Cite

Share

Recognizing Atypical Parkinsonisms: "Red Flags" and Therapeutic Approaches.

McFarland NR, Hess CW. McFarland NR, et al. Semin Neurol. 2017 Apr;37(2):215-227. doi: 10.1055/s-0037-1602422. Epub 2017 May 16. Semin Neurol. 2017. PMID: 28511262 Free PMC article. Review.

Cite

Share

5

Cite

Share

MRI reveals brain abnormalities in drug-naive Parkinson's disease.

Planetta PJ, McFarland NR, Okun MS, Vaillancourt DE. Planetta PJ, et al. Among authors: mcfarland nr. Exerc Sport Sci Rev. 2014 Jan;42(1):12-22. doi: 10.1249/JES.0000000000000003. Exerc Sport Sci Rev. 2014. PMID: 24188978 Free PMC article. Review.

Cite

Share

6

Cite

Share

Movement disorders in 2012: Advancing research towards novel therapeutic approaches.

McFarland NR, Okun MS. McFarland NR, et al. Nat Rev Neurol. 2013 Feb;9(2):70-1. doi: 10.1038/nrneurol.2012.265. Epub 2013 Jan 8. Nat Rev Neurol. 2013. PMID: 23296342 Free PMC article. Review.

Cite

Share

7

Cite

Share

The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism.

Tanner CM, Cummings SR, Schwarzschild MA, Brown EG, Dorsey ER, Espay AJ, Galifianakis NB, Goldman SM, Litvan I, Luthra N, McFarland NR, Mitchell KT, Standaert DG, Bauer DC, Greenspan SL, Beck JC, Lyles KW. Tanner CM, et al. Among authors: mcfarland nr. NPJ Parkinsons Dis. 2021 Mar 1;7(1):16. doi: 10.1038/s41531-021-00162-1. NPJ Parkinsons Dis. 2021. PMID: 33649343 Free PMC article.

Cite

Share

8

Cite

Share

Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophy.

Hass EW, Sorrentino ZA, Lloyd GM, McFarland NR, Prokop S, Giasson BI. Hass EW, et al. Among authors: mcfarland nr. Acta Neuropathol Commun. 2021 May 3;9(1):80. doi: 10.1186/s40478-021-01173-y. Acta Neuropathol Commun. 2021. PMID: 33941284 Free PMC article.

Cite

Share

9

Cite

Share

Anti-tau antibodies: hitting the target.

Golde TE, Lewis J, McFarland NR. Golde TE, et al. Among authors: mcfarland nr. Neuron. 2013 Oct 16;80(2):254-6. doi: 10.1016/j.neuron.2013.10.009. Neuron. 2013. PMID: 24139027 Free article.

Cite

Share

10

Cite

Share

Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.

Archer DB, Mitchell T, Burciu RG, Yang J, Nigro S, Quattrone A, Quattrone A, Jeromin A, McFarland NR, Okun MS, Vaillancourt DE. Archer DB, et al. Among authors: mcfarland nr. Mov Disord. 2020 Aug;35(8):1388-1395. doi: 10.1002/mds.28060. Epub 2020 May 1. Mov Disord. 2020. PMID: 32357259 Free PMC article.

Cite

Share